Search research articles
Contact Us
Filters
Showing results (251-260 of 260) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 260 results.
Molecular Genetics and Genomics : MGG
|
September 8, 2017
Correlation analyses revealed global microRNA-mRNA expression associations in human peripheral blood mononuclear cells
Lan Wang, Jiang Zhu, Fei-Yan Deng, et al.
Functional & Integrative Genomics
|
July 24, 2017
Multiple correlation analyses revealed complex relationship between DNA methylation and mRNA expression in human peripheral blood mononuclear cells
Fang-Fei Xie, Fei-Yan Deng, Long-Fei Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 16, 2018
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
David R Gandara, Joachim von Pawel, Julien Mazieres, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases
|
November 25, 2010
[Atypical pathogens in adult patients admitted with community-acquired pneumonia]
Yi-hong Xiong, Rui Deng, Rong-rong Fu, et al.
Human Genetics
|
March 1, 2017
Integrative multi-omics analysis revealed SNP-lncRNA-mRNA (SLM) networks in human peripheral blood mononuclear cells
Wei Xia, Xiao-Wei Zhu, Xin-Bo Mo, et al.
Urologic Oncology
|
March 20, 2018
Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy
Luke C Peng, Amol K Narang, Carol Gergis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 20, 2018
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer
Louis Fehrenbacher, Joachim von Pawel, Keunchil Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2015
Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer
Marc Peeters, Kelly S Oliner, Timothy J Price, et al.
Calcified Tissue International
|
March 28, 2018
Association of Plasma Irisin with Bone Mineral Density in a Large Chinese Population Using an Extreme Sampling Design
Long-Fei Wu, Dong-Cheng Zhu, Chang-Hua Tang, et al.
Lancet (London, England)
|
December 17, 2016
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 260) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 260 results.
Molecular Genetics and Genomics : MGG
|
September 8, 2017
Correlation analyses revealed global microRNA-mRNA expression associations in human peripheral blood mononuclear cells
Lan Wang, Jiang Zhu, Fei-Yan Deng, et al.
Functional & Integrative Genomics
|
July 24, 2017
Multiple correlation analyses revealed complex relationship between DNA methylation and mRNA expression in human peripheral blood mononuclear cells
Fang-Fei Xie, Fei-Yan Deng, Long-Fei Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 16, 2018
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
David R Gandara, Joachim von Pawel, Julien Mazieres, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases
|
November 25, 2010
[Atypical pathogens in adult patients admitted with community-acquired pneumonia]
Yi-hong Xiong, Rui Deng, Rong-rong Fu, et al.
Human Genetics
|
March 1, 2017
Integrative multi-omics analysis revealed SNP-lncRNA-mRNA (SLM) networks in human peripheral blood mononuclear cells
Wei Xia, Xiao-Wei Zhu, Xin-Bo Mo, et al.
Urologic Oncology
|
March 20, 2018
Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy
Luke C Peng, Amol K Narang, Carol Gergis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 20, 2018
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer
Louis Fehrenbacher, Joachim von Pawel, Keunchil Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2015
Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer
Marc Peeters, Kelly S Oliner, Timothy J Price, et al.
Calcified Tissue International
|
March 28, 2018
Association of Plasma Irisin with Bone Mineral Density in a Large Chinese Population Using an Extreme Sampling Design
Long-Fei Wu, Dong-Cheng Zhu, Chang-Hua Tang, et al.
Lancet (London, England)
|
December 17, 2016
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, et al.
Page
of 26